Glick; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glick; Gary.The latest application filed is for "nlrp modulators".

Company Profile

17.10.17

Glick; Gary - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,447,460 - Glick , et al. September 20, 2	2022-09-20
Nlrp Modulators App 20220267276 - FRANCHI; Luigi ; et al.	2022-08-25
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,370,763 - Franchi , et al. June 28, 2	2022-06-28
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,339,136 - Glick , et al. May 24, 2	2022-05-24
Nlrp Modulators App 20210395241 - GLICK; Gary ; et al.	2021-12-23
Compounds and compositions for treating conditions associated with NLRP activity Grant 11,203,579 - Franchi , et al. December 21, 2	2021-12-21
Compounds And Compositions For Treating Conditions Associated With Sting Activity App 20210236466 - Roush; William R. ; et al.	2021-08-05
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20210230129 - FRANCHI; Luigi ; et al.	2021-07-29
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20210171477 - FRANCHI; Luigi ; et al.	2021-06-10
Compounds And Compositions For Treating Conditions Associated With Sting Activity App 20210147467 - Glick; Gary ; et al.	2021-05-20
Pharmaceutical Formulations App 20210114973 - Glick; Gary ; et al.	2021-04-22
Methods of treatment Grant 10,980,756 - Glick April 20, 2	2021-04-20
Compounds and compositions for treating conditions associated with sting activity Grant 10,961,270 - Glick , et al. March 30, 2	2021-03-30
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer Grant 10,723,756 - Glick , et al.	2020-07-28
Compounds And Compositions For Treating Conditions Associated With Sting Activity App 20200172534 - Roush; William R. ; et al.	2020-06-04
Compounds And Compositions For Treating Conditions Associated With Sting Activity App 20200165288 - Glick; Gary ; et al.	2020-05-28
Compounds and compositions for treating conditions associated with NLRP activity Grant 10,654,816 - Franchi , et al.	2020-05-19
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer Grant 10,604,542 - Glick , et al.	2020-03-31
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20200087270 - FRANCHI; Luigi ; et al.	2020-03-19
NLRP3 modulators Grant 10,533,005 - Glick , et al. Ja	2020-01-14
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20190119203 - Glick; Gary ; et al.	2019-04-25
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20190119241 - Glick; Gary ; et al.	2019-04-25
Compounds And Compositions For Treating Conditions Associated With Nlrp Activity App 20190119224 - Glick; Gary ; et al.	2019-04-25
Nlrp3 Modulators App 20190055236 - Glick; Gary ; et al.	2019-02-21
Cyclic Dinucleotides For Treating Conditions Associated With Sting Activity Such As Cancer App 20190031708 - Glick; Gary ; et al.	2019-01-31
Cyclic Dinucleotides For Treating Conditions Associated With Sting Activity Such As Cancer App 20190016750 - Glick; Gary ; et al.	2019-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.